Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 485,358 |
|
|||||
| News | (5) | ||||||
| Day High | 0.7298 | Low High |
|||||
| Day Low | 0.69 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Spruce Biosciences Inc | SPRB | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0281 | -3.87% | 0.6975 | 00:00:12 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.721 | 0.69 | 0.7298 | 0.6975 | 0.7256 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,730 | 485,358 | $ 0.7105567 | $ 344,874 | - | 0.6711 - 5.95 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:21 | 11 | $ 0.6999 | USD |
Spruce Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 28.5M | 40.71M | - | 10.09M | -47.92M | -1.18 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Spruce Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SPRB Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.7527 | 0.7689 | 0.69 | 0.7447303 | 429,794 | -0.0552 | -7.33% |
| 1 Month | 0.71 | 0.87 | 0.69 | 0.7734472 | 467,254 | -0.0125 | -1.76% |
| 3 Months | 5.01 | 5.95 | 0.6711 | 1.13 | 1,400,941 | -4.31 | -86.08% |
| 6 Months | 1.32 | 5.95 | 0.6711 | 1.58 | 818,347 | -0.6225 | -47.16% |
| 1 Year | 2.50 | 5.95 | 0.6711 | 1.63 | 460,755 | -1.80 | -72.10% |
| 3 Years | 15.06 | 15.08 | 0.6711 | 3.29 | 655,371 | -14.36 | -95.37% |
| 5 Years | 17.00 | 35.60 | 0.6711 | 3.69 | 557,629 | -16.30 | -95.90% |
Spruce Biosciences Description
| Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). |
